このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Acadia Healthcare Company 過去の業績

過去基準チェック /06

Acadia Healthcare Companyは36.9%の年平均成長率で業績を伸ばしているが、Healthcare業界はdecliningで0.9%毎年増加している。売上は成長しており、年平均4.4%の割合である。

主要情報

24.5%

収益成長率

24.4%

EPS成長率

Healthcare 業界の成長	15.7%
収益成長率	7.2%
株主資本利益率	0.1%
ネット・マージン	-0.2%
前回の決算情報	30 Jun 2024

Recent updates

収支内訳

Acadia Healthcare Company の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

DB:7RA 収益、費用、利益 ( )USD Millions
日付	収益	収益	G+A経費
30 Jun 24	3,057	-5	232
31 Mar 24	2,993	-11	228
31 Dec 23	2,929	-22	223
30 Sep 23	2,861	-18	217
30 Jun 23	2,778	271	212
31 Mar 23	2,698	278	208
31 Dec 22	2,610	273	203
30 Sep 22	2,529	282	196
30 Jun 22	2,449	277	190
31 Mar 22	2,380	242	182
31 Dec 21	2,314	203	175
30 Sep 21	2,262	192	169
30 Jun 21	2,223	162	163
31 Mar 21	2,132	144	159
31 Dec 20	2,090	140	158
30 Sep 20	1,230	14	34
30 Jun 20	1,459	20	78
31 Mar 20	1,757	41	117
31 Dec 19	2,008	52	154
30 Sep 19	3,071	-211	319
30 Jun 19	3,054	-208	316
31 Mar 19	3,031	-197	311
31 Dec 18	1,905	57	144
30 Sep 18	2,993	226	300
30 Jun 18	2,949	225	293
31 Mar 18	2,899	216	285
31 Dec 17	2,836	200	273
30 Sep 17	2,815	172	266
30 Jun 17	2,833	9	261
31 Mar 17	2,873	15	266
31 Dec 16	2,811	6	259
30 Sep 16	2,603	-1	236
30 Jun 16	2,348	146	208
31 Mar 16	2,046	124	175
31 Dec 15	1,794	112	149
30 Sep 15	1,594	100	126
30 Jun 15	1,409	96	104
31 Mar 15	1,169	85	80
31 Dec 14	1,005	83	65
30 Sep 14	900	73	58
30 Jun 14	790	62	51
31 Mar 14	754	52	49
31 Dec 13	713	43	47
30 Sep 13	638	35	42

質の高い収益: 7RAは現在利益が出ていません。

利益率の向上: 7RAは現在利益が出ていません。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: 7RAは利益を出していないが、過去 5 年間で年間36.9%の割合で損失を削減してきた。

成長の加速: 7RAの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: 7RAは利益が出ていないため、過去 1 年間の収益成長をHealthcare業界 ( 13.2% ) と比較することは困難です。

株主資本利益率

高いROE: 7RAは現在利益が出ていないため、自己資本利益率 ( -0.12% ) はマイナスです。

Acadia Healthcare Company 過去の業績

過去 基準チェック /06

主要情報

最近の業績更新

Acadia Healthcare Company, Inc. Announces Impairment Charges for Three Months Ended June 30, 2024

Acadia Healthcare Company, Inc. Announces Impairment Charges for Three Months Ended June 30, 2024

Acadia Healthcare Company, Inc. to Report Q2, 2024 Results on Jul 31, 2024

First quarter 2024 earnings released: EPS: US$0.84 (vs US$0.73 in 1Q 2023)

Acadia Healthcare Company, Inc. to Report Q1, 2024 Results on May 01, 2024

Full year 2023 earnings released: US$0.24 loss per share (vs US$3.05 profit in FY 2022)

Recent updates

New minor risk - Share price stability

Acadia Healthcare Company, Inc. Announces Impairment Charges for Three Months Ended June 30, 2024

Acadia Healthcare Company, Inc. Announces Impairment Charges for Three Months Ended June 30, 2024

Acadia Healthcare Company, Inc. to Report Q2, 2024 Results on Jul 31, 2024

Acadia Healthcare Company, Inc. Announces Executive Changes

Acadia Healthcare Company, Inc. Affirms Earnings Guidance for the Year 2024

First quarter 2024 earnings released: EPS: US$0.84 (vs US$0.73 in 1Q 2023)

Acadia Healthcare Company, Inc., Annual General Meeting, May 23, 2024

Acadia Healthcare Company, Inc. to Report Q1, 2024 Results on May 01, 2024

Acadia Healthcare Company, Inc. (NasdaqGS:ACHC) acquired Comprehensive Treatment Center in Greenville, North Carolina.

Acadia Healthcare Company, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024

Full year 2023 earnings released: US$0.24 loss per share (vs US$3.05 profit in FY 2022)

Acadia Healthcare Company, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Director recently sold €3.1m worth of stock

Executive Vice President of Operations recently sold €2.2m worth of stock

Acadia Healthcare Company, Inc. Provides Revenue Guidance for the Year 2023

Third quarter 2023 earnings released: US$2.39 loss per share (vs US$0.79 profit in 3Q 2022)

Acadia Healthcare Company, Inc. to Report Q3, 2023 Results on Nov 02, 2023

Acadia Healthcare Company, Inc. Appoints Dr. Patrice A. Harris as Independent Director

Acadia Healthcare Company, Inc. and Youth and Family Centered Services of New Mexico Provide Update on Civil Litigation in New Mexico State District Court

Washington State Department Of Social And Health Services acquired Cascade Behavioral Health Hospital from Acadia Healthcare Company, Inc. (NasdaqGS:ACHC) for $29.95 million.

Acadia Healthcare Company, Inc. Revises Earnings Guidance for the Year 2023

Second quarter 2023 earnings released: EPS: US$0.79 (vs US$0.89 in 2Q 2022)

Acadia Healthcare Company, Inc. to Report Q2, 2023 Results on Jul 27, 2023

Acadia Healthcare Company, Inc. Announces Executive Changes

Acadia Healthcare Company, Inc. Announces Executive Changes

Acadia Healthcare Company, Inc. Names Judith Scimone as Chief Human Resources Officer

First quarter 2023 earnings released: EPS: US$0.73 (vs US$0.68 in 1Q 2022)

Full year 2022 earnings released: EPS: US$3.05 (vs US$2.29 in FY 2021)

Acadia Healthcare Company, Inc. to Report Q4, 2022 Results on Feb 27, 2023

Acadia Healthcare Company, Inc. Names Laura Groschen as New Chief Information Officer

Acadia Healthcare Company, Inc. (NasdaqGS:ACHC) acquired Four Comprehensive Treatment Centers of Brand New Start Treatment Centers from Brand New Start Treatment Centers.

Third quarter 2022 earnings released: EPS: US$0.79 (vs US$0.74 in 3Q 2021)

Acadia Healthcare Company, Inc. Narrows Revenue Guidance for the Year 2022

Acadia Healthcare Company, Inc. to Report Q3, 2022 Results on Oct 31, 2022

Acadia Healthcare Appoints Nasser Khan to Lead Its CTC Business

Seelos Therapeutics Announces the Participation of Acadia Healthcare in the Registration Directed Study of SLS-002 for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder

Independent Director recently sold €415k worth of stock

Chief Financial Officer recently sold €2.1m worth of stock

Independent Director recently sold €491k worth of stock

Second quarter 2022 earnings released: EPS: US$0.89 (vs US$0.50 in 2Q 2021)

Acadia Healthcare Company, Inc. Provides Earnings Guidance for the Year 2022

Acadia Healthcare Company, Inc. to Report Q2, 2022 Results on Jul 27, 2022

Acadia Healthcare Company, Inc. Appoints R. David Kelly as Independent Director

Acadia Healthcare Company, Inc. Announces Reeve B. Waud Resigns Effective Immediately from Each of the Audit and Risk Committee and Nominating and Governance Committee of the Board of Directors

Acadia Healthcare Company, Inc. Provides Revenue Guidance for the Full Year 2022

First quarter 2022 earnings released: EPS: US$0.68 (vs US$0.25 in 1Q 2021)

Acadia Healthcare Company, Inc. to Report Q1, 2022 Results on May 03, 2022

Acadia Healthcare Company, Inc., Annual General Meeting, May 19, 2022

Acadia Healthcare Announces Christopher Hunter as Director

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Acadia Healthcare Company, Inc. Provides Revenue Guidance for the First Quarter End Full Year 2022

Acadia Healthcare Company, Inc. to Report Q4, 2021 Results on Feb 28, 2022

Acadia Healthcare Company, Inc. Announces Retirement of Debbie Osteen as Chief Executive Officer

Acadia Healthcare Company, Inc. (NasdaqGS:ACHC) acquired CenterPointe Behavioral Health System LLC.

Acadia Healthcare Company, Inc. (NasdaqGS:ACHC) acquired three non-operational facilities located in Chicago.

Third quarter 2021 earnings released: EPS US$0.74 (vs US$0.42 in 3Q 2020)

Acadia Healthcare Company, Inc. Provides Earnings Guidance for 2021

Second quarter 2021 earnings released: EPS US$0.001 (vs US$0.47 in 2Q 2020)

Executive Vice President of Operations recently sold €273k worth of stock

First quarter 2021 earnings released: EPS US$0.25 (vs US$0.38 in 1Q 2020)

Acadia Healthcare Company, Inc. Provides Revenue Guidance for the Year 2021

Independent Director recently sold €201k worth of stock

New 90-day high: €46.40

Full year 2020 earnings released: EPS US$1.60 (vs US$1.24 in FY 2019)

Acadia Healthcare Company, Inc. to Report Q4, 2020 Results on Feb 25, 2021

Acadia Healthcare Company, Inc. (NasdaqGS:ACHC) has signed a definitive agreement to acquire Vallejo behavioral health services of Adventist Health from Adventist Health Vallejo.

New 90-day high: €44.00

Waterland Private Equity Fund VII, fund managed by Waterland Private Equity Investments BV agreed to acquire Priory Group Limited from Acadia Healthcare Company, Inc. (NasdaqGS:ACHC) for £1.1 billion.

過去基準チェック /06